Treatment of maxillary ameloblastoma with different modalities: a retrospective analysis of 92 cases

doi:10.19439/j.sjos.2022.01.015

Abstract

Abstract: PURPOSE: To explore the appropriate surgical approach for each type of maxillary ameloblastoma. METHODS: The clinical data of 92 patients with maxillary ameloblastoma were retrospectively analyzed. All patients were pathologically diagnosed, followed up for 3-8 years after surgery, maxillofacial CT and panoramic images were taken regularly to observe the surgical outcomes. SPSS 22.0 software package was used for data analysis. RESULTS: The proportion of maxillary ameloblastoma in male and female patients was 3 to 1,with more male patients and the mean age was 45.77 years old. The total recurrence rate of 92 patients was 21.74%, among which unicystic ameloblastoma had no recurrence after different surgical procedures. Among 38 patients with typical maxillary ameloblastoma, 14 underwent curettage, 3 underwent decompression,16 underwent extended resection, 3 underwent subtotal maxillary resection, 1 underwent iliac bone transplantation after subtotal maxillary resection, and 1 underwent reconstruction with anterolateral thigh flap after subtotal maxillary resection. Among them, 18 had recurrence and 5 had canceration. Three patients with extrasseous/peripheral type underwent expanded resection and two underwent curettage,none of them had recurrence. One patient with metastasizing ameloblastoma recurred after extended resection. CONCLUSIONS: Maxillary ameloblastoma with unicystic type should be completely removed with minimal trauma. The recurrence rate of maxillary ameloblastoma via simple curettage or extended resection is still relatively high, which may be due to the large tumor involvement scope of these patients and the failure of complete tumor removal by curettage. For external/peripheral ameloblastoma and metastatic ameloblastoma, the involved jaw bone should be removed as much as possible to prevent recurrence. For malignant transformation of ameloblastoma, the tumor and jaw bone should be dissected during the operation to reduce recurrence rate. The primary site, cervical lymph nodes and lungs should be closely followed after operation to detect early metastasis.

Key words: Maxilla, Ameloblastoma, Decompression, Curettage, Recurrence

CLC Number:

R739.8

LUO Hao, YUAN Zhuang, WU Kai-liu, HE Jie, MENG Jian. Treatment of maxillary ameloblastoma with different modalities: a retrospective analysis of 92 cases[J]. Shanghai Journal of Stomatology, 2022, 31(1): 71-74.

References

[1] Neagu D, Escuder-de la Torre O, Vázquez-Mahía I, et al. Surgical management of ameloblastoma. review of literature[J]. J Clin Exp Dent, 2019, 11(1): e70-e75.
[2] 刘浏, 张新宇, 胡永杰, 等. 890例颌骨成釉细胞瘤发病构成比分析[J].口腔颌面外科杂志, 2015, 25(3): 213-215.
[3] Agbaje JO, Olumuyiwa Adisa A, Ivanova Petrova M, et al.Biological profile of ameloblastoma and its location in the jaw in 1246 Nigerians[J].Ora Surg Oral Med Oral Pathol Oral Radiol, 2018, 126(5): 424-431.
[4] El-Naggar AK, Chan JKC, Grandis JR, et al.WHO classification of head and neck tumours[M]. Lyon: IARC Press, 2017: 217-218.
[5] Hendra FN, Van Cann EM, Helder MN, et al.Global incidence and profile of ameloblastoma: a systematic review and meta-analysis[J]. Oral Dis, 2020, 26(1): 12-21.
[6] Effiom OA, Ogundana OM, Akinshipo AO, et al.Ameloblastoma: current etiopathological concepts and management[J]. Oral Dis, 2018, 24(3): 307-316.
[7] 吴敏, 钟旖, 谢家翔, 等. 单囊型成釉细胞瘤20例临床病理分析[J].诊断病理学杂志, 2019, 26(1): 11-14.
[8] Wright JM, Vered M.Update from the 4th edition of the World Health Organization classification of head and neck tumours: odontogenic and maxillofacial bone tumors[J]. Head Neck Pathol, 2017, 11(1): 68-77.
[9] Song IS, Park HS, Seo BM, et al.Effect of decompression on cystic lesions of the mandible: 3-dimensional volumetric analysis[J]. Br J Oral Maxillofac Surg, 2015, 53(9): 841-848.
[10] 杨子楠, 梁倩, 杨乐, 等. 下颌骨单囊型成釉细胞瘤开窗治疗回顾性分析[J]. 实用口腔医学杂志, 2020, 36(3): 454-458.
[11] Liang YJ, He WJ, Zheng PB, et al.Inferior alveolar nerve function recovers after decompression of large mandibular cystic lesions[J].Oral Dis, 2015, 21(5): 674-678.
[12] 张立刚, 易杰, 姚礼, 等. 单囊型成釉细胞瘤行开窗减压术联合刮治术的临床研究[J]. 口腔医学研究, 2020, 36(4): 341-345.
[13] Haq J, Siddiqui S, Mcgurk M.Argument for the conserva-tive management of mandibular ameloblastomas[J]. Br J Oral Maxillofac Surg, 2016, 54(9): 1001-1005.
[14] Kumar M, Iyer VK, Mathur S, et al.Granular cell ameloblastoma-diagnosis on aspiration cytology[J]. Diagn Cytopathol, 2019, 47(10): 1120-1122.
[15] 陆长玺, 郭传瑸.成釉细胞瘤侵袭深度的初步测量研究[J].现代口腔医学杂志, 2019, 33(5): 270-273.
[16] Siriwardena BSMS, Tennakoon TMPB, Hunter KD, et al.Unicystic ameloblastoma: analysis of 370 cases in a single center in Sri Lanka[J]. J Oral Pathol Med, 2018, 47(7): 706-709.
[17] Gupta A, Das SN, Patro S, et al.Fine-needle aspiration cytology as a useful diagnostic adjunct in the management of ameloblastoma: a report of four cases[J]. Natl J Maxillofac Surg, 2018, 9(1): 103-105.
[18] Datta R, Winston JS, Diaz-Reyes G, et al.Ameloblastic carcinoma: report of an aggressive case with multiple bony metastases[J]. Am J Otolaryngol, 2003, 24(1): 64-69.
[19] Yoon HJ, Hong SP, Lee JI, et al.Ameloblastic carcinoma: an analysis of 6 cases with review of the literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009, 108(6): 904-913.
[20] Takayama K, Nakamura T, Takada A, et al.Proton beam therapy combined with retrograde intra-arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: a case report[J]. Mol Clin Oncol, 2020, 13(4): 34-40.
[21] Hong YT, Hong KH.Primary ameloblastic carcinoma of the neck[J]. Ear Nose Throat J, 2020, 99(4): 268-269.